Medically prescribed heroin more effective, less costly than current methadone treatment

March 12, 2012

Medically prescribed heroin is more cost-effective than methadone for treating long-term street heroin users, according to a new study by researchers at Providence Health Care and the University of British Columbia.

The study, published today in the (), attributed most of the economic benefits to the fact that recipients of medically prescribed heroin (diacetylmorphine) stayed in treatment longer and spent less time in than those receiving . Both results are associated with reduced criminal activity and lower health care costs.

Additionally, an individual in the diacetylmorphine group was more likely to live longer than someone receiving methadone .

The findings were drawn from the North American Opiate Medication Initiative (NAOMI), a trial of medically prescribed heroin that took place in Vancouver from 2005 to 2008, as well as administrative drug data from British Columbia. NAOMI was North America's first-ever clinical trial of prescribed heroin.

The researchers – led by Dr. Aslam Anis, director of the Centre for Health Evaluation and Outcome Sciences (CHÉOS) at Providence Health Care and professor in UBC's School of Population and Public Health – used a cost-effectiveness analysis to compare treatments over a one-, five- and 10-year period, as well as a lifetime horizon.

Those in the methadone therapy group generated an average lifetime societal cost of $1.14 million per person, while those in the diacetylmorphine group generated a lesser cost of $1.09 million. The study considered treatment expenditures, estimated costs for drug therapies and costs borne by the justice system.

"NAOMI demonstrated that heroin-assisted therapy is a more effective treatment option than MMT, but now, thanks to this study, we can also confidently say that there are significant of using this medication," Dr. Anis says.

"The question I get most about heroin-assisted therapy is whether we can afford the increased direct costs of the treatment," says co-author Dr. Martin Schechter, a CHÉOS scientist and professor at UBC's School of Population and Public Health. "What this study shows is that the more appropriate question is whether we can afford not to."

The NAOMI study, which was also led by researchers from PHC, CHÉOS and UBC, was a randomized trial aimed at testing whether medically prescribed heroin was more effective than methadone therapy for individuals who were not currently benefiting from conventional treatment.

The results, published in the New England Journal of Medicine, showed that patients treated with the prescribed heroin were more likely to stay in treatment or quit heroin altogether and more likely to reduce their use of illegal drugs and other illegal activities than patients treated with oral methadone.

Explore further: UBC-Providence Health research to examine new treatments for heroin addiction

Related Stories

UBC-Providence Health research to examine new treatments for heroin addiction

October 12, 2011
A clinical trial to test better treatment options for chronic heroin addiction is expected to begin in Vancouver at the end of this year. Led by researchers from Providence Health Care and the University of British Columbia, ...

Suboxone is most effective in treating painkiller addiction

November 7, 2011
Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's ...

Recommended for you

Marijuana use amongst youth stable, but substance abuse admissions up

August 15, 2017
While marijuana use amongst youth remains stable, youth admission to substance abuse treatment facilities has increased, according to new research from Binghamton University, State University of New York.

Report reveals underground US haven for heroin, drug users

August 8, 2017
A safe haven where drug users inject themselves with heroin and other drugs has been quietly operating in the United States for the past three years, a report reveals.

Regular energy drink use linked to later drug use among young adults

August 8, 2017
Could young adults who regularly consume highly caffeinated energy drinks be at risk for future substance use? A new study by University of Maryland School of Public Health researchers, published in the journal Drug and Alcohol ...

Gamblers more likely to have suffered childhood traumas, research shows

August 2, 2017
Men with problem and pathological gambling addictions are more likely to have suffered childhood traumas including physical abuse or witnessing violence in the home, according to new research.

Incorporating 12-step program elements improves youth substance-use disorder treatment

July 26, 2017
A treatment program for adolescents with substance-use disorder that incorporates the practices and philosophy of 12-step programs like Alcoholics Anonymous (AA) produced even better results than the current state-of-the ...

Concern with potential rise in super-potent cannabis concentrates

July 21, 2017
University of Queensland researchers are concerned the recent legalisation of medicinal cannabis in Australia may give rise to super-potent cannabis concentrates with associated harmful effects.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.